Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
Anesa Mulabecirovic, Portfolio Manager at DNB Asset Management, shared a post on LinkedIn:
“The most common inherited bleeding disorder takes an average of sixteen years to diagnose in women.
Not because it is rare. It is not. The delay is about where the bleeding gets recorded.
A girl can bleed heavily from her first period, and the note that follows reads ‘heavy periods,’ not ‘possible clotting defect.’
She is routed to gynecology, not hematology. The symptom is counted. The disorder behind it is not.
Global registries identify von Willebrand disease in roughly 26 people per million.
Clinically significant disease runs closer to 1 in 1000.
Either way the treated population is a fraction of the real one, and the gap is a recording problem, not a biology one.
A market can only price what has a label.
The clinic meets the patient before the label exists, and that gap is larger than the numbers suggest.”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering